Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer

NIH RePORTER · NIH · R01 · $92,860 · view on reporter.nih.gov ↗

Abstract

Abstract Abstract not requested. This is an NCI Diversity Supplement to Dr. Cullen Taniguchi's Grant# 1R01CA227517-01A1, titled, Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer.

Key facts

NIH application ID: 10134891
Project number: 3R01CA227517-02S1
Recipient: UNIVERSITY OF TX MD ANDERSON CAN CTR
Principal Investigator: Cullen Mitsuo Taniguchi
Activity code: R01
Funding institute: NIH
Fiscal year: 2020
Award amount: $92,860
Award type: 3
Project period: 2019-04-01 → 2024-03-31